Feng Shan

A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth <i>In vivo</i> and Prevents Tumor Recurrence after Surgical Resection

Eiji Suzuki, Samuel Kim, Hung Kam Cheung et al. · Cancer Research · 2007 · 113 citations

Intracellular TGF-β Receptor Blockade Abrogates Smad-Dependent Fibroblast Activation In Vitro and In Vivo

Wataru Ishida, Yasuji Mori, Gabriella Lakos et al. · Journal of Investigative Dermatology · 2006 · 88 citations · Full text

Fibrosis, Immunology, Fibroblast Growth Factor +6

SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

Kai Fu, Michael J. Corbley, Lihong Sun et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2008 · 84 citations · Full text

Enteral nutrition feeding in Chinese intensive care units: a cross-sectional study involving 116 hospitals

Juan Xing, Zhongheng Zhang, Lu Ke et al. · Critical Care · 2018 · 46 citations · Full text

Increased plasma nesfatin-1 levels may be associated with corticosterone, IL-6, and CRP levels in patients with major depressive disorder

Qingrong Xia, Jun Liang, Yin Cao et al. · Clinica Chimica Acta · 2018 · 40 citations

Inflammation, Psychoneuroimmunology, Stress Hormone +12